Osmunda (奥咨达)

Guangzhou-based medical-device services group founded in 2004 by Dr. Zhang Feng and Pan Wei; it pioneered the medical-device CRO industry in China and runs the first one-stop comprehensive CXO platform for devices, spanning R&D design (CDO), clinical and regulatory registration (CRO) and contract manufacturing (CDMO). Serves more than 5,000 device clients worldwide, including 70% of listed Chinese device makers, has helped commercialize over 3,600 devices, and pairs its shared-production-capacity model with OSMED, a proprietary medical-device vertical large language model. Closed a RMB 100M Series D in November 2026, solely invested by the Lishui Green Valley Talent Osmunda New Fund, to build its headquarters MAH mass-production facility and an AI innovation platform.

  • B2B
  • Series C+
  • Clinical Trials
  • Healthtech
  • Medical Devices
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 13, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 13, 2026

    CNY 100M

    Series C+

    Led by Lishui Green Valley Talent Osmunda New Fund (丽水市绿谷人才奥咨达新基金)

    • Lishui Green Valley Talent Osmunda New Fund (丽水市绿谷人才奥咨达新基金)

    Osmunda (奥咨达) Raises RMB 100M Series C+ to Build MAH Facility and AI Platform

    Osmunda (奥咨达) Closes RMB 100M Series C+ Guangzhou based medical device services group Osmunda (奥咨达) has closed a RMB 100 million Series C+ round, according to…

    Read article

Pricing

Research Osmunda (奥咨达) — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Osmunda (奥咨达) is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational